Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.

PHASE3UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 27, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Venous Thromboembolism
Interventions
OTHER

Debriefing and educative components

The patient will receive early debriefing and enhanced educative components added to a standardized visit at one month

OTHER

Without debriefing and educative components

Patient will receive a standardized visit alone (without debriefing and enhanced educative components ) at one month

Trial Locations (10)

29240

RECRUITING

HIA Brest, Brest

29609

RECRUITING

CHRU de Brest, Brest

31059

RECRUITING

CHU de Toulouse - Hôpital de Rangueil, Toulouse

35203

NOT_YET_RECRUITING

CHU de Rennes - Hôpital Sud, Rennes

38700

RECRUITING

CHU de Grenoble - Hôpital Nord Michallon, Grenoble

42055

RECRUITING

CHU de Saint Etienne - Hôpital Nord, Saint-Etienne

49933

NOT_YET_RECRUITING

CHU Angers, Angers

63003

RECRUITING

CHU de Clermont Ferrand - Hôpital Gabriel Montpied, Clermont-Ferrand

75015

RECRUITING

HEGP, Paris

92700

RECRUITING

APHP Hôpital Louis Mourier, Colombes

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University Hospital, Brest

OTHER

NCT04141254 - Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. | Biotech Hunter | Biotech Hunter